What is the biggest risk facing Meiya Pico?

The biggest risk is that AI-driven tools for transcription, OCR, and password recovery are shrinking the value of the software layer Meiya Pico traditionally charged for, even inside its protected home market. On top of that, domestic rivals iFlytek and Venustech Group compete for the same government forensics contracts, contributing to gross profit falling from ¥1,342 million in 2021 to ¥540 million in 2024. Watch the FY2026 interim results, expected around H1 2026, for whether losses narrow or widen again.

Is Meiya Pico in financial trouble?

Yes, by the numbers: net loss has widened for three straight years, from -¥206 million in 2023 to -¥415 million in 2024 to -¥782 million in 2025. Revenue was around ¥1.76 billion as of 2026-01-09, down 10.42% year over year, though the company remains shielded from foreign competition by its state-backed status and Entity List protections through the end of 2026.

Who are Meiya Pico's biggest competitors?

Domestically, iFlytek, Venustech Group, and Feitian Technologies compete for the same Chinese government forensics contracts and are chipping away at Meiya Pico's forensic tool value. Internationally, Cellebrite leads Western public-sector mobile forensics with roughly 45-50% share among Western buyers, but it is barred from selling into China by US export controls, so it poses no direct domestic threat as of the 2026 assessment.

Is Meiya Pico at risk from AI?

Partly. General-purpose AI tools now handle tasks like transcription and password recovery that Meiya Pico used to charge for as specialized software, which is eroding the value of its traditional forensic tools even within its own protected market. This threat is rated as building rather than distant in the 2026 assessment, meaning it is an active pressure rather than a settled outcome.

How does Meiya Pico compare to similar companies?

Within its cohort of 12 companies also losing its protection, Meiya Pico stands out as one of the stronger performers, largely because its home market is legally closed to foreign rivals. Its listing on the US Treasury's Non-SDN Chinese Military-Industrial Complex list and the Commerce Entity List keeps competitors like Cellebrite out of China entirely, giving it a moat that most peers in the cohort lack. That said, its own financial trend undercuts the picture: net loss widened from -¥206 million in 2023 to -¥782 million in 2025, revenue fell 10.42% year over year as of 2026-01-09, and gross profit dropped from ¥1,342 million in 2021 to ¥540 million in 2024, as domestic rivals iFlytek, Venustech Group, and Feitian Technologies compete for the same government contracts.

Could a foreign company like Cellebrite take over Meiya Pico's market?

Not directly, at least through the end of 2026. Meiya Pico's listing on the US Treasury's Non-SDN Chinese Military-Industrial Complex list and the Commerce Entity List locks out foreign rivals like Cellebrite from selling into China, so the giant threat status is classified as distant rather than active. The bigger pressure comes from domestic players and AI tools eroding value from within, not from foreign competitors taking share.

Cybersecurity companies · state-owned · China

Meiya Pico

meiya.com.cn ↗

Chinese state-owned firm that extracts phone data for police forensic investigations.

Losing its protection

Assessed 31 July 2026 · Evidence as of 31 July 2026

The structural protection is eroding.

On the recordSince 31 July 2026 · Checkable from Q4 2026 · Every call on the record Checkpoint: FY2026 H1 and full-year earnings report, watched for revenue stabilization or continued decline

The call

State backing keeps Meiya Pico alive inside China's closed police-procurement market, but revenue keeps falling and losses keep widening.

Meiya Pico sells tools that law enforcement use to extract data from phones. The company has a shield built in: the Chinese government owns it and only buys from Chinese vendors, which keeps foreign competitors like Cellebrite and Magnet out. But that shield does not protect it from Chinese rivals like Longxin and Pangu, and it does not stop the bigger problem: phones are getting harder to unlock because of encryption, so the whole business is shrinking. Revenue dropped from 1.98 billion yuan to 1.41 billion yuan in two years, losses tripled to 782 million yuan, and the company cut 40 percent of its workforce. The company is trying to pivot to artificial intelligence and cloud forensics to replace the old phone-extraction business, but there is no sign that the new products are making money. The one thing that could change the picture is if the artificial intelligence shift actually works and shows up as profit in the first half of 2026. Without that, the company will just keep bleeding money while the government keeps it alive.

Why

AI pressure: Domestic AI-forensics rivals (Pangu, Longxin) plus phone encryption from Apple and Google. AI speeds up password cracking and data triage, but stronger phone encryption cuts into the core handset-extraction business itself. Could AI do the core job? Only partly.

Bigger players: Domestic rivals Longxin, Pangu, Pinghang, Xin Ren. These rivals compete for the same closed Ministry of Public Security contracts while Meiya's revenue and headcount keep shrinking. Could a giant copy it? Probably.

What protects it. State ownership and closed government procurement keep foreign vendors like Cellebrite and MSAB out of China's police market.

What would change this call

Meiya Pico's FY2026 H1 earnings show revenue decline continuing or reversing. Confirms whether domestic rivals and encryption trends keep eroding its core business.
A named domestic rival wins a flagship Ministry of Public Security or provincial bureau contract. Direct evidence a Chinese competitor is displacing Meiya Pico in its protected market.
New US or EU sanctions naming Meiya Pico or SDIC Intelligence specifically. Would tighten the Entity List drag and further isolate its overseas business.

Key numbers

FY2025 revenue fell 20% YoY to CNY 1.41B (2026-07-03)
FY2025 net loss widened 88% YoY to CNY 782M (2026-07-24)
Market cap down 31.5% YoY to CNY 8.57B (2026-07-24)

Named risks

Revenue fell 20% YoY in FY2025 while net loss nearly doubled to ¥782 million. Severity: high
US Entity List sanctions since 2019 and 2021 CMIC investment restrictions limit capital access and reputation. Severity: high
Domestic rivals Longxin, Pangu, Pinghang, Xin Ren compete for the same shrinking government budget. Severity: medium
Encryption trends structurally erode core handset-extraction business globally. Severity: medium
Ongoing human-rights reporting on Tibet and Africa surveillance ties could trigger further sanctions or export controls. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Longxin, Pangu, Pinghang, Xin Ren (domestic Chinese rivals)	contesting	Named as most capable Chinese police forensics vendors contesting shrinking budget pool, as of 2026-04
Cellebrite	losing to	Global market leader marketing AI-driven cloud/social-media analysis as successor to handset extraction, 2025-08
Magnet Forensics / GrayKey	losing to	Described as Cellebrite's primary North American rival in an evolving AI-forensics market, 2026-03
MSAB, Oxygen Forensics, Exterro	gaining on	Named global peers pivoting to cloud/AI forensics as encryption erodes classic extraction, 2025-08

Questions people ask

What is the biggest risk facing Meiya Pico?: The biggest risk is that AI-driven tools for transcription, OCR, and password recovery are shrinking the value of the software layer Meiya Pico traditionally charged for, even inside its protected home market. On top of that, domestic rivals iFlytek and Venustech Group compete for the same government forensics contracts, contributing to gross profit falling from ¥1,342 million in 2021 to ¥540 million in 2024. Watch the FY2026 interim results, expected around H1 2026, for whether losses narrow or widen again.
Is Meiya Pico in financial trouble?: Yes, by the numbers: net loss has widened for three straight years, from -¥206 million in 2023 to -¥415 million in 2024 to -¥782 million in 2025. Revenue was around ¥1.76 billion as of 2026-01-09, down 10.42% year over year, though the company remains shielded from foreign competition by its state-backed status and Entity List protections through the end of 2026.
Who are Meiya Pico's biggest competitors?: Domestically, iFlytek, Venustech Group, and Feitian Technologies compete for the same Chinese government forensics contracts and are chipping away at Meiya Pico's forensic tool value. Internationally, Cellebrite leads Western public-sector mobile forensics with roughly 45-50% share among Western buyers, but it is barred from selling into China by US export controls, so it poses no direct domestic threat as of the 2026 assessment.
Is Meiya Pico at risk from AI?: Partly. General-purpose AI tools now handle tasks like transcription and password recovery that Meiya Pico used to charge for as specialized software, which is eroding the value of its traditional forensic tools even within its own protected market. This threat is rated as building rather than distant in the 2026 assessment, meaning it is an active pressure rather than a settled outcome.
How does Meiya Pico compare to similar companies?: Within its cohort of 12 companies also losing its protection, Meiya Pico stands out as one of the stronger performers, largely because its home market is legally closed to foreign rivals. Its listing on the US Treasury's Non-SDN Chinese Military-Industrial Complex list and the Commerce Entity List keeps competitors like Cellebrite out of China entirely, giving it a moat that most peers in the cohort lack. That said, its own financial trend undercuts the picture: net loss widened from -¥206 million in 2023 to -¥782 million in 2025, revenue fell 10.42% year over year as of 2026-01-09, and gross profit dropped from ¥1,342 million in 2021 to ¥540 million in 2024, as domestic rivals iFlytek, Venustech Group, and Feitian Technologies compete for the same government contracts.
Could a foreign company like Cellebrite take over Meiya Pico's market?: Not directly, at least through the end of 2026. Meiya Pico's listing on the US Treasury's Non-SDN Chinese Military-Industrial Complex list and the Commerce Entity List locks out foreign rivals like Cellebrite from selling into China, so the giant threat status is classified as distant rather than active. The bigger pressure comes from domestic players and AI tools eroding value from within, not from foreign competitors taking share.

Timeline

2026-07-24Market cap down to ~¥8.57B, -31.5% YoY; TTM revenue ~¥1.36B, down ~24% YoY
2026-05-30Showcased AI/big-data forensics products at BRICS New Industrial Revolution Exhibition, Xiamen
2025-10Legal entity renamed SDIC Intelligence Information Technology Co., Ltd.
2025-07-15Lookout documents 'Massistant' mobile forensic tool, successor to MFSocket, still used by Chinese police
2025-04-22Reports document Meiya Pico providing cyber-ops training and forensic lab to Tibet Police College
2023-12Company renamed SDIC Intelligence Xiamen Information Co.; also granted South African patent for multi-modal social-relationship analysis
2021Listed under US Chinese Military-Industrial Complex executive order restricting US investment in shares
2019-10-07Added to US Commerce Department Entity List over Xinjiang human rights concerns
2011-03-16IPO on Shenzhen Stock Exchange ChiNext board under ticker 300188
1999-09-22Company founded as computer-sales business, later pivoting to digital forensics around 2003

Head to head

Cellebrite vs Meiya Pico

Revision history

31 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Seqrite NSFOCUS Qi An Xin (Qianxin)